Karuna Therapeutics Inc KRTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/05/22 EDT
140.36UNCH (UNCH)
Volume
5,469
Close
140.36quote price arrow up+5.96 (+4.43%)
Volume
463,195
52 week range
92.26 - 161.98
Loading...
  • Open134.76
  • Day High142.56
  • Day Low131.64
  • Prev Close134.40
  • 52 Week High161.98
  • 52 Week High Date11/05/21
  • 52 Week Low92.26
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap4.194B
  • Shares Out29.88M
  • 10 Day Average Volume0.27M
  • Dividend-
  • Dividend Yield-
  • Beta1.6
  • YTD % Change7.15

KEY STATS

  • Open134.76
  • Day High142.56
  • Day Low131.64
  • Prev Close134.40
  • 52 Week High161.98
  • 52 Week High Date11/05/21
  • 52 Week Low92.26
  • 52 Week Low Date05/12/22
  • Market Cap4.194B
  • Shares Out29.88M
  • 10 Day Average Volume0.27M
  • Dividend-
  • Dividend Yield-
  • Beta1.6
  • YTD % Change7.15

RATIOS/PROFITABILITY

  • EPS (TTM)-5.78
  • P/E (TTM)-24.27
  • Fwd P/E (NTM)-17.26
  • EBITDA (TTM)-171.842M
  • ROE (TTM)-33.03%
  • Revenue (TTM)36.96M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-464.04%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO4:1504:15
The economy has fallen into the technical definition of a recession, says Kevin Mahn

Profile

MORE
Karuna Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on creating and delivering transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate, KarXT, is an oral modulator of muscarinic receptors that are located both in the central nervous system (CNS) and various peripheral tissues. It is initially developing KarXT, for the treatment of acute psychosis in patients with...
Steven Paul M.D.
Chairman of the Board, President, Chief Executive Officer, Director
Andrew Miller Ph.D.
Chief Operating Officer
Troy Ignelzi
Chief Financial Officer, Company Secretary
Address
99 High Street, 26Th Floor
Boston, MA
02110
United States

Top Peers

SYMBOLLASTCHG%CHG
CERE
Cerevel Therapeutics Holdings Inc
33.47+3.97+13.46%
TPTX
Turning Point Therapeutics Inc
74.97-0.28-0.37%
ZLAB
Zai Lab Ltd
45.27+4.44+10.87%
CYTK
Cytokinetics Inc
51.82+5.10+10.92%
DNLI
Denali Therapeutics Inc
35.75+2.35+7.04%